Comparing Belsomra vs Quviviq
| Belsomra (suvorexant) | Quviviq (daridorexant) |
|
|---|
| Belsomra (suvorexant) | Quviviq (daridorexant) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Insomnia. Belsomra may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Insomnia. Quviviq may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||
| More about Belsomra (suvorexant) | More about Quviviq (daridorexant) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Belsomra has an average rating of 3.9 out of 10 from a total of 540 ratings on Drugs.com. 27% of reviewers reported a positive effect, while 62% reported a negative effect. |
Quviviq has an average rating of 5.1 out of 10 from a total of 154 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 46% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Belsomra side effects |
View all Quviviq side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Belsomra prices |
View all Quviviq prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
12 hours |
8 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 493 drugs are known to interact with Belsomra:
|
A total of 681 drugs are known to interact with Quviviq:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
August 13, 2014 |
January 07, 2022 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.